Raymond L. Woosley, M.D., Ph.D. Appointed to ARCA biopharma Board of Directors

ARCA biopharma, Inc. , a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that Raymond L. Woosley, M.D., Ph.D, has been appointed to the Company's Board of Directors.

http://www.businesswire.com/news/topix/20130730005857/en